Veracyte Revenue vs. Net Income
| VCYT Stock | USD 41.66 0.66 1.61% |
Total Revenue | First Reported 2011-12-31 | Previous Quarter 130.2 M | Current Value 131.9 M | Quarterly Volatility 39.1 M |
For Veracyte profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Veracyte to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Veracyte utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Veracyte's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Veracyte over time as well as its relative position and ranking within its peers.
Veracyte's Revenue Breakdown by Earning Segment
Check out World Market Map.
Veracyte Revenue Breakdown by Earning Segment
By analyzing Veracyte's earnings estimates, investors can diagnose different trends across Veracyte's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Veracyte. If investors know Veracyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Veracyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.263 | Earnings Share 0.38 | Revenue Per Share | Quarterly Revenue Growth 0.138 | Return On Assets |
The market value of Veracyte is measured differently than its book value, which is the value of Veracyte that is recorded on the company's balance sheet. Investors also form their own opinion of Veracyte's value that differs from its market value or its book value, called intrinsic value, which is Veracyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Veracyte's market value can be influenced by many factors that don't directly affect Veracyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Veracyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Veracyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Veracyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Veracyte Net Income vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Veracyte's current stock value. Our valuation model uses many indicators to compare Veracyte value to that of its competitors to determine the firm's financial worth. Veracyte is rated fourth in revenue category among its peers. It is rated first in net income category among its peers making up about 0.05 of Net Income per Revenue. The ratio of Revenue to Net Income for Veracyte is roughly 18.47 . At this time, Veracyte's Total Revenue is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Veracyte by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Veracyte Revenue vs. Competition
Veracyte is rated fourth in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 3.57 Billion. Veracyte retains roughly 445.76 Million in revenue claiming about 12% of equities under Health Care industry.
Veracyte Net Income vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Veracyte |
| = | 445.76 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Veracyte |
| = | 24.14 M |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Veracyte Net Income Comparison
Veracyte is currently under evaluation in net income category among its peers.
Veracyte Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Veracyte, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Veracyte will eventually generate negative long term returns. The profitability progress is the general direction of Veracyte's change in net profit over the period of time. It can combine multiple indicators of Veracyte, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -32.5 M | -30.9 M | |
| Operating Income | 14.5 M | 15.3 M | |
| Income Before Tax | 23.2 M | 24.3 M | |
| Total Other Income Expense Net | 11 M | 11.6 M | |
| Net Income | 21.7 M | 22.8 M | |
| Income Tax Expense | 1.4 M | 1.5 M | |
| Net Income From Continuing Ops | 27.8 M | 29.1 M | |
| Non Operating Income Net Other | 5.4 M | 5.6 M | |
| Net Loss | -32.9 M | -34.5 M | |
| Interest Income | 12.8 M | 13.5 M | |
| Net Interest Income | 12.8 M | 13.5 M | |
| Change To Netincome | 31.8 M | 33.3 M | |
| Net Income Per Share | 0.28 | 0.30 | |
| Income Quality | 2.80 | 2.94 | |
| Net Income Per E B T | 0.84 | 0.77 |
Veracyte Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Veracyte. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Veracyte position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Veracyte's important profitability drivers and their relationship over time.
Veracyte Earnings per Share Projection vs Actual
Use Veracyte in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Veracyte position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Veracyte will appreciate offsetting losses from the drop in the long position's value.Veracyte Pair Trading
Veracyte Pair Trading Analysis
The ability to find closely correlated positions to Veracyte could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Veracyte when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Veracyte - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Veracyte to buy it.
The correlation of Veracyte is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Veracyte moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Veracyte moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Veracyte can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Veracyte position
In addition to having Veracyte in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hedge Favorites Thematic Idea Now
Hedge Favorites
Hedge Funds pool capital from accredited individuals or institutional investors and invest in a variety of assets, often with complex portfolio-construction and risk-management techniques. The Hedge Favorites theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hedge Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Veracyte Stock Analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.